Cibus (CBUS) Scheduled to Post Earnings on Thursday

Cibus (NASDAQ:CBUSGet Free Report) is set to release its earnings data after the market closes on Thursday, August 8th. Analysts expect Cibus to post earnings of ($0.81) per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Cibus (NASDAQ:CBUSGet Free Report) last released its quarterly earnings data on Thursday, May 9th. The company reported ($1.12) EPS for the quarter, missing the consensus estimate of ($1.01) by ($0.11). The business had revenue of $0.55 million during the quarter, compared to analysts’ expectations of $0.40 million. Cibus had a negative net margin of 12,313.28% and a negative return on equity of 23.33%. During the same period last year, the company earned ($5.45) earnings per share. On average, analysts expect Cibus to post $-3 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Cibus Trading Up 0.4 %

Shares of CBUS stock traded up $0.03 during trading hours on Tuesday, hitting $8.24. The company’s stock had a trading volume of 104,801 shares, compared to its average volume of 104,870. The company has a 50 day moving average of $10.19 and a 200 day moving average of $15.29. The stock has a market cap of $177.57 million, a PE ratio of -0.45 and a beta of 1.91. Cibus has a 12-month low of $7.41 and a 12-month high of $23.18.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CBUS. Canaccord Genuity Group raised shares of Cibus to a “strong-buy” rating in a report on Friday, July 19th. Alliance Global Partners initiated coverage on shares of Cibus in a report on Monday, July 29th. They set a “buy” rating and a $25.00 price target on the stock. Canaccord Genuity Group reissued a “buy” rating and set a $22.00 price target on shares of Cibus in a report on Friday, July 19th. Finally, HC Wainwright reissued a “buy” rating and set a $25.00 price target on shares of Cibus in a report on Friday, May 10th.

Check Out Our Latest Analysis on Cibus

About Cibus

(Get Free Report)

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.

Recommended Stories

Earnings History for Cibus (NASDAQ:CBUS)

Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.